Spread antibacterial therapy, which carried out according to therapeutic and preventive schemes is considered to be a highly effective and the most rational tool for controlling infectious diseases under the conditions of large industrial pig breeding enterprises. It has been found that long-term intramuscular use of the drug Tulatrin in a therapeutic and three-fold therapeutic dose did not have an expressed pathological effect on the body of pigs. During the experiment, no animal dead and manifestationed of clinical signs of intoxication (depression, vomiting, salivation, diarrhea, etc.) have been noted. The animals were active and had feed intake well. The live weight of piglets in the experimental groups did not significantly differ from the animals that were housed in the control groups. The liver was the most sensitive to the action of tulatromycin with prolonged intake of the drug in elevated doses, which has been confirmed by the results of biochemical studies. However, the intrinsic hepatotoxicity associated with the use of high doses or prolonged use was characteristic of all drugs of the macrolide group. It should be noted that in this case, the maximum increase in marker liver enzymes did not exceed 10 % of the upper limit of the norm, so we could say that the liver damage was of a trace nature, since the clinical significance was the increase in liver samples by at least 2 times. Also, the increase in total protein was not fatal and did not affect the change in the clinical status of the animals. We did not note the death of animals and the manifestation of clinical signs of intoxication and hepatopathy. Tulatrin is one of the safe medicines, and is characterized by good tolerability. The results obtained confirm the safety of using the drug in the recommended dosage regimen.